These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34764807)

  • 1. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
    Nassif MA
    Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
    Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
    Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum interleukin-2 receptor
    Tian JY; Zhang X; Cheng G; Liu QH; Wang SY; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1083-1087. PubMed ID: 34916686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Urinary Interleukin-6 in Assessment of Renal Activity in Egyptian Patients with Systemic Lupus Erythematosus.
    El-Shereef RR; Lotfi A; Abdel-Naeam EA; Tawfik H
    Clin Med Insights Arthritis Musculoskelet Disord; 2016; 9():29-36. PubMed ID: 26966395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
    Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
    Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
    Xia LP; Li BF; Shen H; Lu J
    Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
    Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
    Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
    Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
    Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study.
    Molad Y; Egbaria M; Tovar A; Dortort Lazar A; Pokroy Shapira E; Oren S; Edel Y; Kliminski V
    Clin Exp Rheumatol; 2023 May; 41(5):1155-1162. PubMed ID: 36622114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.